Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

+6.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Victor Cassella who wrote (631)	11/8/1997 9:30:00 AM
From: Kip518	Read Replies (1) of 1605

To all: Did anyone see the ABC News report on Friday night about an experimental drug called VEGF? Accoring to the report VEGF is a new way of treating heart disease: genetically engineering NEW blood vessels to literally grow new arteries! It could make the pain and risk of some heart surgery irrelevant! Imagine bypassing bypass surgery! (ref: abcnews.com. According to the report, a presentation on VEGF will be at the AHA meeting. I think Jennings also said drug could be available in 3-5 months (sounds implausible given certification requirements, but if the drug is herbally based might be a short time to market). I know nothing more about this than what Jennings reported, but it sounds like it be big trouble for VASO. Does anyone on the thread know anything more about VEGF? Thanks, Ron

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next